Influence of bone quality on stress distribution for endosseous implants.

The present study examined the influence of bone quality on the transmission of occlusal forces for endosseous dental implants. Employing the finite element method, the study modeled a 3.75 x 10-mm threaded implant placed in a 12 x 11 x 8-mm section of bone. By varying the elastic parameters assigned to the bone elements, four bone quality categories were established. A load of 100 N was applied at the occlusal surface of the restoration at a 30 degrees angle to the vertical axis of the implant. Maximum von Mises stress concentrations (sigma Emax) were observed to be located in the marginal bone at the coronal aspect of the implant fixture in all four cases. Values of sigma Emax were 13.7 MPa for type 1 bone, 15.8 MPa for type 2 bone, 20.1 MPa for type 3 bone, and 26.5 MPa for type 4 bone. Magnitude of the stresses in bone was strongly correlated (r = 0.997) with computed displacement of the implant system. This analysis predicts that placement of implants in bone with greater thickness of the cortical shell and greater density of the core will result in less micromovement and reduced stress concentration, thereby increasing the likelihood of fixture stabilization and tissue integration.

Developmental and behavioral effects of prenatal primidone exposure in the rat.

Pregnant Sprague-Dawley rats were administered primidone (PRM) by oral gavage on gestation days 8-17 in doses of 0.40, and 80 mg/kg. Although these doses of PRM did not produce significant differences in litter size, birth weight, mortality, date of attainment of developmental landmarks or measures of preweaning reflex and motor development, there were a number of significant differences that developed as the animals approached and entered adulthood. When tested as adults, the 80 mg/kg male rats showed a deficit in the performance of an eight-arm radial maze task. These same animals showed a significant reduction in open field activity when tested as adults. In addition, both male and female PRM-treated animals showed reduced body weights at different periods corresponding to onset of sexual maturation during development. These findings are consistent with the larger body of literature reporting on the neurobehavioral teratology of phenobarbital, including its ability to produce lesions in the hippocampus and endocrine dysfunction resulting in reproductive deficits. These results suggest that PRM produces its adverse effects as a result of its metabolism to phenobarbital, which in turn affects the limbic system.